SCHEMBL3982422

SCHEMBL3982422

CCNC(=O)Nc1nn(Cc2ccc(F)cc2)c(=O)c2c(O)c3n(c12)CCN(C)C3=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CNR2 P34972 4/20 0.33
CNR1 P21554 3/20 0.33
MAPT P10636 3/20 0.33
PKM P14618 1/20 0.33
PKLR P30613 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HDAC3 O15379 3/20 0.33
HDAC4 P56524 3/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC7 Q8WUI4 3/20 0.33
HDAC2 Q92769 3/20 0.33
HDAC10 Q969S8 3/20 0.33
HDAC11 Q96DB2 3/20 0.33
HDAC8 Q9BY41 3/20 0.33
HDAC6 Q9UBN7 3/20 0.33
HDAC9 Q9UKV0 3/20 0.33
HDAC5 Q9UQL6 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3987450 0.91 POLB (0.35) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3985559 0.86 CYP2C9 (0.34) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3984969 0.83 PKM (0.38) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3985794 0.82 PKM (0.37) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3983532 0.82 PKM (0.44) TMEM97SIGMAR1MAPTPKMPKLR
SCHEMBL3983836 0.81 PKM (0.39) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3985497 0.80 PKM (0.37) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL1383893 0.80 PKM (0.37) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3981562 0.79 MAPT (0.37) TMEM97SIGMAR1CNR2CNR1MAPT
SCHEMBL3987610 0.79 PKM (0.36) TMEM97SIGMAR1CNR2CNR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP claimed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US claimed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US claimed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP TMEM97 2707/4885SIGMAR1 1891/4885CNR2 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.